These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37944672)

  • 1. A statewide population-based approach to examining Long COVID symptom prevalence and predictors in Michigan.
    Hirschtick JL; Xie Y; Slocum E; Hirschtick RE; Power LE; Elliott MR; Orellana RC; Fleischer NL
    Prev Med; 2023 Dec; 177():107752. PubMed ID: 37944672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics.
    Hirschtick JL; Titus AR; Slocum E; Power LE; Hirschtick RE; Elliott MR; McKane P; Fleischer NL
    Clin Infect Dis; 2021 Dec; 73(11):2055-2064. PubMed ID: 34007978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional population-based estimates of a rural-urban disparity in prevalence of long COVID among Michigan adults with polymerase chain reaction-confirmed COVID-19, 2020-2022.
    MacCallum-Bridges CL; Hirschtick JL; Allgood KL; Ryu S; Orellana RC; Fleischer NL
    J Rural Health; 2024 Mar; 40(2):303-313. PubMed ID: 37974389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-Month Symptom Profiles Among Symptomatic Adults With Positive and Negative Severe Acute Respiratory Syndrome Coronavirus 2 Tests: A Prospective Cohort Study From the INSPIRE Group.
    Spatz ES; Gottlieb M; Wisk LE; Anderson J; Chang AM; Gentile NL; Hill MJ; Huebinger RM; Idris AH; Kinsman J; Koo K; Li SX; McDonald S; Plumb ID; Rodriguez RM; Saydah S; Slovis B; Stephens KA; Unger ER; Wang RC; Yu H; Hota B; Elmore JG; Weinstein RA; Venkatesh A
    Clin Infect Dis; 2023 May; 76(9):1559-1566. PubMed ID: 36573005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    ; Wulf Hanson S; Abbafati C; Aerts JG; Al-Aly Z; Ashbaugh C; Ballouz T; Blyuss O; Bobkova P; Bonsel G; Borzakova S; Buonsenso D; Butnaru D; Carter A; Chu H; De Rose C; Diab MM; Ekbom E; El Tantawi M; Fomin V; Frithiof R; Gamirova A; Glybochko PV; Haagsma JA; Haghjooy Javanmard S; Hamilton EB; Harris G; Heijenbrok-Kal MH; Helbok R; Hellemons ME; Hillus D; Huijts SM; Hultström M; Jassat W; Kurth F; Larsson IM; Lipcsey M; Liu C; Loflin CD; Malinovschi A; Mao W; Mazankova L; McCulloch D; Menges D; Mohammadifard N; Munblit D; Nekliudov NA; Ogbuoji O; Osmanov IM; Peñalvo JL; Petersen MS; Puhan MA; Rahman M; Rass V; Reinig N; Ribbers GM; Ricchiuto A; Rubertsson S; Samitova E; Sarrafzadegan N; Shikhaleva A; Simpson KE; Sinatti D; Soriano JB; Spiridonova E; Steinbeis F; Svistunov AA; Valentini P; van de Water BJ; van den Berg-Emons R; Wallin E; Witzenrath M; Wu Y; Xu H; Zoller T; Adolph C; Albright J; Amlag JO; Aravkin AY; Bang-Jensen BL; Bisignano C; Castellano R; Castro E; Chakrabarti S; Collins JK; Dai X; Daoud F; Dapper C; Deen A; Duncan BB; Erickson M; Ewald SB; Ferrari AJ; Flaxman AD; Fullman N; Gamkrelidze A; Giles JR; Guo G; Hay SI; He J; Helak M; Hulland EN; Kereselidze M; Krohn KJ; Lazzar-Atwood A; Lindstrom A; Lozano R; Malta DC; Månsson J; Mantilla Herrera AM; Mokdad AH; Monasta L; Nomura S; Pasovic M; Pigott DM; Reiner RC; Reinke G; Ribeiro ALP; Santomauro DF; Sholokhov A; Spurlock EE; Walcott R; Walker A; Wiysonge CS; Zheng P; Bettger JP; Murray CJL; Vos T
    JAMA; 2022 Oct; 328(16):1604-1615. PubMed ID: 36215063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Dive into the Long Haul: Analysis of Symptom Clusters and Risk Factors for Post-Acute Sequelae of COVID-19 to Inform Clinical Care.
    Goldhaber NH; Kohn JN; Ogan WS; Sitapati A; Longhurst CA; Wang A; Lee S; Hong S; Horton LE
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female gender is associated with long COVID syndrome: a prospective cohort study.
    Bai F; Tomasoni D; Falcinella C; Barbanotti D; Castoldi R; Mulè G; Augello M; Mondatore D; Allegrini M; Cona A; Tesoro D; Tagliaferri G; Viganò O; Suardi E; Tincati C; Beringheli T; Varisco B; Battistini CL; Piscopo K; Vegni E; Tavelli A; Terzoni S; Marchetti G; Monforte AD
    Clin Microbiol Infect; 2022 Apr; 28(4):611.e9-611.e16. PubMed ID: 34763058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-Control Study of Long COVID, Sapporo, Japan.
    Asakura T; Kimura T; Kurotori I; Kenichi K; Hori M; Hosogawa M; Saijo M; Nakanishi K; Iso H; Tamakoshi A
    Emerg Infect Dis; 2023 May; 29(5):956-966. PubMed ID: 37044126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-Related Quality of Life for Patients with Post-Acute COVID-19 Syndrome: Identification of Symptom Clusters and Predictors of Long-Term Outcomes.
    Lapin B; Li Y; Englund K; Katzan IL
    J Gen Intern Med; 2024 Jun; 39(8):1301-1309. PubMed ID: 38424349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
    Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
    Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM
    J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler Looking for Clarity in the Haze of the Pandemic.
    Huang Y; Pinto MD; Borelli JL; Asgari Mehrabadi M; Abrahim HL; Dutt N; Lambert N; Nurmi EL; Chakraborty R; Rahmani AM; Downs CA
    Clin Nurs Res; 2022 Nov; 31(8):1390-1398. PubMed ID: 36154716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who develops long COVID? Longitudinal pre-pandemic predictors of long COVID and symptom clusters in a representative Dutch population.
    Slurink IAL; van den Houdt SCM; Mertens G
    Int J Infect Dis; 2024 Jul; 144():107048. PubMed ID: 38609036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    medRxiv; 2020 Oct; ():. PubMed ID: 33106813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Palm P; Nygaard U; Bundgaard H; Petersen MNS; Rosenkilde S; Thorsted AB; Ersbøll AK; Thygesen LC; Nielsen SD; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Sep; 6(9):614-623. PubMed ID: 35752194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian KK; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    PLoS One; 2021; 16(3):e0241875. PubMed ID: 33760821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution.
    Robineau O; Zins M; Touvier M; Wiernik E; Lemogne C; de Lamballerie X; Blanché H; Deleuze JF; Saba Villarroel PM; Dorival C; Nicol J; Gomes-Rima R; Correia E; Coeuret-Pellicer M; Druesne-Pecollo N; Esseddik Y; Ribet C; Goldberg M; Severi G; Carrat F;
    JAMA Netw Open; 2022 Nov; 5(11):e2240985. PubMed ID: 36350653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological post-acute sequelae of SARS-CoV-2 infection.
    Takao M; Ohira M
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.